BNP Paribas Financial Markets’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80 Hold
44
﹤0.01% 4519
2025
Q1
$89 Sell
44
-101
-70% -$204 ﹤0.01% 4428
2024
Q4
$868 Sell
145
-2,629
-95% -$15.7K ﹤0.01% 4249
2024
Q3
$27.1K Sell
2,774
-14,297
-84% -$140K ﹤0.01% 2991
2024
Q2
$350K Buy
17,071
+15,712
+1,156% +$322K ﹤0.01% 2187
2024
Q1
$61.3K Sell
1,359
-105
-7% -$4.74K ﹤0.01% 2882
2023
Q4
$69.1K Sell
1,464
-3,302
-69% -$156K ﹤0.01% 2781
2023
Q3
$193K Buy
4,766
+391
+9% +$15.8K ﹤0.01% 2441
2023
Q2
$466K Sell
4,375
-2,736
-38% -$292K ﹤0.01% 2033
2023
Q1
$2.12M Buy
7,111
+4,900
+222% +$1.46M ﹤0.01% 1308
2022
Q4
$760K Sell
2,211
-1,162
-34% -$399K ﹤0.01% 1723
2022
Q3
$638K Sell
3,373
-562
-14% -$106K ﹤0.01% 2168
2022
Q2
$831K Sell
3,935
-1,271
-24% -$268K ﹤0.01% 1756
2022
Q1
$1.74M Buy
5,206
+1,029
+25% +$344K ﹤0.01% 1476
2021
Q4
$1.36M Buy
4,177
+2,597
+164% +$845K ﹤0.01% 1827
2021
Q3
$767K Buy
1,580
+464
+42% +$225K ﹤0.01% 1990
2021
Q2
$519K Buy
1,116
+556
+99% +$258K ﹤0.01% 1953
2021
Q1
$386K Buy
560
+473
+544% +$326K ﹤0.01% 2178
2020
Q4
$64.4K Sell
87
-102
-54% -$75.6K ﹤0.01% 2784
2020
Q3
$131K Buy
189
+50
+36% +$34.7K ﹤0.01% 2367
2020
Q2
$118K Buy
139
+8
+6% +$6.77K ﹤0.01% 2091
2020
Q1
$46.7K Buy
131
+75
+134% +$26.7K ﹤0.01% 2958
2019
Q4
$13K Buy
56
+37
+195% +$8.6K ﹤0.01% 3428
2019
Q3
$2.1K Buy
19
+18
+1,800% +$1.99K ﹤0.01% 3709
2019
Q2
$175 Buy
+1
New +$175 ﹤0.01% 3834